Objectives. To determine whether needle biopsy of the posterolateral aspect
s of the prostate aids in prostate cancer detection. In the routine sextant
biopsy strategy, the posterolateral aspects of the prostate are not sample
d.
Methods. Using an 18-gauge biopsy gun, we performed sextant biopsies and an
additional nine needle biopsies in the pathology laboratory on 150 radical
prostatectomy specimens performed for Stage Tie prostate cancer. The addit
ional nine biopsies consisted of three midline biopsies and six (three each
from the left and right) posterolaterally aimed biopsies from the apex, mi
d, and base regions of the gland. Significant tumors were defined as those
greater than 0.5 cm(3), or with a Gleason score of 7 or greater, or non-org
an confined.
Results. Of the 123 cases with cancer on repeated biopsy, in only 3 (2.4%)
was the only cancer found in the midline biopsies. For the following analys
is, we analyzed the data as if we had not done the midline biopsies. If one
had performed only the routine sextant needle biopsies, in 31 (25.2%) of t
he 123 cases, tumor would have been missed; 20 of these tumors were signifi
cant, including 5 with extraprostatic extension. If one had performed only
the more posterolateral six biopsies, in 15 cases (12.2%), tumor would have
been missed; 5 of these tumors were significant, all of which were organ c
onfined.
Conclusions. Adding routine midline biopsies does not appreciably increase
the detection of cancer. If one were to only perform six needle biopsies of
the prostate, these biopsies should be aimed more toward the posterolatera
l aspect of the gland. Maximum cancer detection results from combining both
routine sextant and posterolateral needle biopsies. UROLOGY 57: 1112-1116,
2001, (C) 2001, Elsevier Science Inc.